Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Specific genomic DNA sequence in hepatocytes
- Molecular classification
- Other (genomic DNA sequence, epigenetic marker)
01
Overview
A specific genomic DNA sequence in hepatocytes refers to unique regions within liver cell DNA that can be distinguished from DNA in other tissue types, often through epigenetic signatures like unmethylated CpG islands adjacent to genes such as ITIH4, IGF2R, and VTN. These sequences serve as precise biomarkers in applications such as monitoring liver injury, transplantation, and cell-type identification, but do not constitute a functional molecular target for drug intervention or therapeutic modulation. They are principally used in liquid biopsy analyses, cell-free DNA assays, and basic research into cell-specific gene regulation. Given these facts, this entry is not a canonical molecular target and should be further specified or replaced with a gene, receptor, or protein for structured bioinformatics purposes.
- Other names
- Hepatocyte-specific DNA methylation markerHepatocyte-specific genomic locus
02
Mechanism of action
Not applicable. Genomic DNA sequences are not drug targets, though drugs can modulate related epigenetic marks.
03
Biological functions
Cell identity determination (cell-type marker for hepatocytes)Epigenetic regulation (if referring to methylation signatures)Detection of cell death (via circulating cell-free DNA)
04
Disease associations
Liver injury (monitoring hepatocyte death)Liver transplantation monitoringBiomarker for disease (not a disease driver itself)
05
Safety considerations
Not applicable as a direct therapeutic target.Some technical limitations may exist for sensitivity, specificity of detection, and interpretation of results in clinical settings
06
Interacting drugs
None. Genomic DNA sequences themselves do not interact with drugs; however, drugs may affect DNA methylation patterns indirectly.
07
Biomarkers
Unmethylated CpG loci near ITIH4, IGF2R, VTN are used as hepatocyte-specific biomarkers for circulating cell-free DNA
Beyond the preview
Go deeper on Specific genomic DNA sequence in hepatocytes.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Specific genomic DNA sequence in hepatocytes.